Cargando…
DMU-212 against EGFR-mutant non-small cell lung cancer via AMPK/PI3K/Erk signaling pathway
Although some important advances have been achieved in clinical and diagnosis in the past few years, the management of non-small cell lung cancer (NSCLC) is ultimately dissatisfactory due to the low overall cure and survival rates. Epidermal growth factor (EGFR) has been recognized as a carcinogenic...
Autores principales: | Zhao, Xiao-Ping, Zheng, Xiao-Li, Huang, Min, Xie, Ya-Jia, Nie, Xiao-Wen, Nasim, Ali Adnan, Yao, Xiao-Jun, Fan, Xing-Xing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10256861/ https://www.ncbi.nlm.nih.gov/pubmed/37305501 http://dx.doi.org/10.1016/j.heliyon.2023.e15812 |
Ejemplares similares
-
In Vivo Metabolite Profiling of DMU-212 in Apc(Min/+) Mice Using UHPLC-Q/Orbitrap/LTQ MS
por: Li, Jing, et al.
Publicado: (2023) -
The Effect of 3′-Hydroxy-3,4,5,4′-Tetramethoxy -stilbene, the Metabolite of the Resveratrol Analogue DMU-212, on the Motility and Proliferation of Ovarian Cancer Cells
por: Nowicki, Andrzej, et al.
Publicado: (2020) -
3′-hydroxy-3,4,5,4′-tetramethoxystilbene, the metabolite of resveratrol analogue DMU-212, inhibits ovarian cancer cell growth in vitro and in a mice xenograft model
por: Piotrowska-Kempisty, Hanna, et al.
Publicado: (2016) -
The Effect of 4′-hydroxy-3,4,5-trimetoxystilbene, the Metabolite of Resveratrol Analogue DMU-212, on Growth, Cell Cycle and Apoptosis in DLD-1 and LOVO Colon Cancer Cell Lines
por: Jozkowiak, Malgorzata, et al.
Publicado: (2020) -
Steroidogenic activity of liposomal methylated resveratrol analog 3,4,5,4′-tetramethoxystilbene (DMU-212) in human luteinized granulosa cells in a primary three-dimensional in vitro model
por: Józkowiak, Małgorzata, et al.
Publicado: (2023)